MicroRNA control in the development of systemic autoimmunity.

Abstract:

:Mammalian immune responses are intended to eradicate microbial pathogens and thus protect individuals from the harmful effects of such infections. However, unresolved inflammation can be devastating to the host and cause tissue damage and organ malfunction. Immune responses can even mistakenly target self-antigens and mediate autoimmune inflammation. Consequently, a variety of cellular and molecular mechanisms have evolved to control the inflammatory responses, and many of these safeguards or triggers are perturbed in the setting of autoimmunity. In this review, we discuss the emerging roles of cellular non-coding RNAs, and in particular microRNAs (miRNAs), in the regulation of autoimmune inflammation. How miRNAs function to impact the onset, magnitude, and resolution of inflammatory responses and recent observations regarding links between miRNAs and specific autoimmune disorders will be addressed. Finally, the diagnostic and therapeutic relevance of miRNAs involved in autoimmunity will be considered. It is clear that, taken together, mammalian miRNAs are integral to the pathogenesis of mammalian autoimmune diseases and may be effective targets of next-generation therapeutics aimed at eradicating tissue inflammation.

journal_name

Arthritis Res Ther

authors

Hu R,O'Connell RM

doi

10.1186/ar4131

subject

Has Abstract

pub_date

2013-01-25 00:00:00

pages

202

issue

1

eissn

1478-6354

issn

1478-6362

pii

ar4131

journal_volume

15

pub_type

杂志文章,评审
  • Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes.

    abstract:INTRODUCTION:Osteoporosis of the axial skeleton is a known complication of ankylosing spondylitis (AS), but bone loss affecting the peripheral skeleton is less studied. This study on volumetric bone mineral density (vBMD) and bone microarchitecture in AS was conducted to compare peripheral vBMD in AS patients with that...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4368

    authors: Klingberg E,Lorentzon M,Göthlin J,Mellström D,Geijer M,Ohlsson C,Atkinson EJ,Khosla S,Carlsten H,Forsblad-d'Elia H

    更新日期:2013-01-01 00:00:00

  • Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis.

    abstract:INTRODUCTION:Our objectives were to examine mononuclear cell gene expression profiles in patients with systemic lupus erythematosus (SLE) and healthy controls and to compare subsets with and without atherosclerosis to determine which genes' expression is related to atherosclerosis in SLE. METHODS:Monocytes were obtain...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4609

    authors: Korman BD,Huang CC,Skamra C,Wu P,Koessler R,Yao D,Huang QQ,Pearce W,Sutton-Tyrrell K,Kondos G,Edmundowicz D,Pope R,Ramsey-Goldman R

    更新日期:2014-07-10 00:00:00

  • Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes.

    abstract:INTRODUCTION:Nucleus pulposus (NP) cells have a phenotype similar to articular cartilage (AC) cells. However, the matrix of the NP is clearly different to that of AC suggesting that specific cell phenotypes exist. The aim of this study was to identify novel genes that could be used to distinguish bovine NP cells from A...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2929

    authors: Minogue BM,Richardson SM,Zeef LA,Freemont AJ,Hoyland JA

    更新日期:2010-01-01 00:00:00

  • Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis.

    abstract:INTRODUCTION:Adjustment of infliximab dosage for individuals may be useful in improving therapeutic response in rheumatoid arthritis (RA). Herein, we aimed to determine whether measurement of infliximab serum concentration modifies the therapeutic decision and improves the control of disease activity. METHODS:RA patie...

    journal_title:Arthritis research & therapy

    pub_type: 临床试验,杂志文章

    doi:10.1186/ar2867

    authors: Mulleman D,Méric JC,Paintaud G,Ducourau E,Magdelaine-Beuzelin C,Valat JP,Goupille P,Centre National de la Recherche Scientifique UMR 6239 GICC.

    更新日期:2009-01-01 00:00:00

  • Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms.

    abstract:BACKGROUND:Proprotein convertase subtilisin kexin 9 (PCSK9) targets the LDL-receptor (LDLR) which raises LDL-levels. In addition, PCSK9 has proinflammatory immunological effects. Here, we investigate the role of PCSK9 in relation to the inflammatory activity in patients with rheumatoid arthritis (RA). METHODS:PCSK9-le...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02386-7

    authors: Frostegård J,Ahmed S,Hafström I,Ajeganova S,Rahman M

    更新日期:2021-01-19 00:00:00

  • A patient-reported questionnaire developed in a German early arthritis cohort to assess periodontitis in patients with rheumatoid arthritis.

    abstract:BACKGROUND:The aim of this study was to develop a patient-reported questionnaire that is suitable to detect periodontitis (PD) in patients with rheumatoid arthritis (RA). METHODS:A self-reported questionnaire containing 12 items potentially relevant to PD and dentists' semiquantitative assessment of PD (no/mild/modera...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s13075-019-1982-z

    authors: Callhoff J,Dietrich T,Chubrieva M,Klotsche J,Zink A

    更新日期:2019-08-29 00:00:00

  • Beyond cognitive-behavioral therapy for fibromyalgia: addressing stress by emotional exposure, processing, and resolution.

    abstract::I comment on the well-designed trial by Alda and colleagues reported in a recent issue of Arthritis Research and Therapy which demonstrated some benefits of cognitive-behavioral therapy (CBT) for fibromyalgia (FM). CBT in this and other studies provides statistically significant but rather modest benefits for FM. This...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3511

    authors: Lumley MA

    更新日期:2011-01-01 00:00:00

  • Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition.

    abstract::The enzyme methionine aminopeptidase-2 (MetAP-2) is thought to play an important function in human endothelial cell proliferation, and as such provides a valuable target in both inflammation and cancer. Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased synovial vascularity, and henc...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2340

    authors: Bainbridge J,Madden L,Essex D,Binks M,Malhotra R,Paleolog EM

    更新日期:2007-01-01 00:00:00

  • Vasculogenesis in rheumatoid arthritis.

    abstract::Decreased number and impaired functions of endothelial progenitor cells (EPCs) leading to impaired vasculogenesis have been associated with rheumatoid arthritis (RA). Defective vasculogenesis has also been implicated in premature atherosclerosis in RA. Recently, early-outgrowth monocytic and late-outgrowth hemangiobla...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar2943

    authors: Szekanecz Z,Koch AE

    更新日期:2010-01-01 00:00:00

  • Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis.

    abstract:BACKGROUND:The mechanisms underlying tolerance induction and maintenance in autoimmune arthritis remain elusive. In a mouse model of rheumatoid arthritis, collagen type II (CII)-induced arthritis, we explore the contribution of B cells to antigen-specific tolerance. METHODS:To generate expression of the CII-peptide sp...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-1037-7

    authors: Andersson SE,Eneljung T,Tengvall S,Jirholt P,Stern A,Henningsson L,Liang B,Thorarinsdottir K,Kihlberg J,Holmdahl R,Mårtensson IL,Gustafsson K,Gjertsson I

    更新日期:2016-06-14 00:00:00

  • Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

    abstract:INTRODUCTION:Tumor necrosis factor (TNF) antagonists reduce the signs and symptoms of spondyloarthritides, including ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Our objective was to evaluate the effectiveness and safety of adalimumab, 40 mg every other week, for patients with AS or PsA and prior treatmen...

    journal_title:Arthritis research & therapy

    pub_type: 临床试验,杂志文章

    doi:10.1186/ar3054

    authors: Rudwaleit M,Van den Bosch F,Kron M,Kary S,Kupper H

    更新日期:2010-01-01 00:00:00

  • Neural immune pathways and their connection to inflammatory diseases.

    abstract::Inflammation and inflammatory responses are modulated by a bidirectional communication between the neuroendocrine and immune system. Many lines of research have established the numerous routes by which the immune system and the central nervous system (CNS) communicate. The CNS signals the immune system through hormona...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar1002

    authors: Eskandari F,Webster JI,Sternberg EM

    更新日期:2003-01-01 00:00:00

  • Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects.

    abstract:INTRODUCTION:A number of genetic-association studies have identified genes contributing to ankylosing spondylitis (AS) susceptibility but such approaches provide little information as to the gene activity changes occurring during the disease process. Transcriptional profiling generates a 'snapshot' of the sampled cells...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3309

    authors: Pimentel-Santos FM,Ligeiro D,Matos M,Mourão AF,Costa J,Santos H,Barcelos A,Godinho F,Pinto P,Cruz M,Fonseca JE,Guedes-Pinto H,Branco JC,Brown MA,Thomas GP

    更新日期:2011-04-07 00:00:00

  • Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.

    abstract:BACKGROUND:Although the short-term effects of tumor necrosis factor alpha (TNF-α) and interleukin-17A (IL-17A) inhibition on the structural changes in psoriatic arthritis (PsA) using high-resolution peripheral quantitative computed tomography (HR-pQCT) have been reported, no studies have investigated the long-term stru...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-019-2043-3

    authors: Wu D,Griffith JF,Lam SHM,Wong PCH,Shi L,Li EK,Cheng IT,Li TK,Hung VW,Qin L,Tam LS

    更新日期:2019-12-04 00:00:00

  • Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage.

    abstract:INTRODUCTION:Prostaglandin D synthase (PGDS) is responsible for the biosynthesis of PGD and J series, which have been shown to exhibit anti-inflammatory and anticatabolic effects. Two isoforms have been identified: hematopoietic- and lipocalin-type PGDS (H-PGDS and L-PGDS, respectively). The aims of this study were to ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2581

    authors: Zayed N,Li X,Chabane N,Benderdour M,Martel-Pelletier J,Pelletier JP,Duval N,Fahmi H

    更新日期:2008-01-01 00:00:00

  • More about masitinib.

    abstract::A dose-escalating phase II trial studied masitinib, an oral tyrosine kinase inhibitor, in 43 patients with rheumatoid arthritis. Masitinib induced American College of Rheumatology (ACR)20, ACR50 and ACR70 responses in 54%, 26% and 8% of patients, respectively. A placebo group was not included. Thirty-seven per cent of...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar2734

    authors: Walker UA

    更新日期:2009-01-01 00:00:00

  • Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study.

    abstract:INTRODUCTION:Vagus nerve stimulation (VNS) exerts beneficial anti-inflammatory effects in various animal models of inflammation, including collagen-induced arthritis, and is implicated in representing a novel therapy for rheumatoid arthritis. However, evidence of anti-inflammatory effects of VNS in humans is very scarc...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s13075-015-0667-5

    authors: Kox M,van Eijk LT,Verhaak T,Frenzel T,Kiers HD,Gerretsen J,van der Hoeven JG,Kornet L,Scheiner A,Pickkers P

    更新日期:2015-06-07 00:00:00

  • The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age.

    abstract:INTRODUCTION:Interleukin-1 (IL-1) blockade is the treatment of choice of cryopyrin associated periodic syndromes (CAPS). Anti-IL-1 monoclonal antibody (canakinumab) was recently registered. However no clear data are available on the optimal schedule of administration of this drug. The aim of the present study was to an...

    journal_title:Arthritis research & therapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/ar4184

    authors: Caorsi R,Lepore L,Zulian F,Alessio M,Stabile A,Insalaco A,Finetti M,Battagliese A,Martini G,Bibalo C,Martini A,Gattorno M

    更新日期:2013-02-26 00:00:00

  • A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies.

    abstract::Anti-glucose-6-phosphate isomerase (GPI) antibodies are known to be arthritogenic autoantibodies in K/BxN mice, although some groups have reported that few healthy humans retain these antibodies. The expression of Fcgamma receptors (FcgammaRs) is genetically regulated and has strong implications for the development of...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1802

    authors: Matsumoto I,Zhang H,Muraki Y,Hayashi T,Yasukochi T,Kori Y,Goto D,Ito S,Tsutsumi A,Sumida T

    更新日期:2005-01-01 00:00:00

  • Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain.

    abstract:BACKGROUND:To understand the impact of yet undiagnosed non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) on work outcomes in a cohort of patients with long-lasting chronic low back pain (CLBP). METHODS:Data were used from a primary care CLBP cohort that was established to understand t...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-017-1333-x

    authors: van Hoeven L,Boonen AERCH,Hazes JMW,Weel AEAM

    更新日期:2017-06-17 00:00:00

  • Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group.

    abstract:BACKGROUND:The long-term outcome of rheumatoid arthritis (RA) patients who in clinical practice exhibit persistent moderate disease activity (pMDA) despite treatment with biologics has not been adequately studied. Herein, we analyzed the 5-year outcome of the pMDA group and assessed for within-group heterogeneity. MET...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02313-w

    authors: Genitsaridi I,Flouri I,Plexousakis D,Marias K,Boki K,Skopouli F,Drosos A,Bertsias G,Boumpas D,Sidiropoulos P

    更新日期:2020-09-29 00:00:00

  • Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment.

    abstract:INTRODUCTION:The patient's perspective is becoming increasingly important in clinical and policy decisions. In this study, we aimed to evaluate the preferences of patients with, or at risk of, osteoporosis for medication attributes, and to establish how patients trade between these attributes. METHODS:A discrete choic...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4465

    authors: Hiligsmann M,Dellaert BG,Dirksen CD,van der Weijden T,Goemaere S,Reginster JY,Watson V,Boonen A

    更新日期:2014-01-31 00:00:00

  • HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients.

    abstract:INTRODUCTION:The revised shared epitope (SE) concept in rheumatoid arthritis (RA) is based on the presence (S) or absence (X) of the SE RAA amino acid motif at positions 72 to 74 of the third hypervariable region of the various human leucocyte antigen (HLA)-DRB1 alleles. The purpose of this study was to investigate SE ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3479

    authors: Meyer PW,Hodkinson B,Ally M,Musenge E,Wadee AA,Fickl H,Tikly M,Anderson R

    更新日期:2011-01-01 00:00:00

  • Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.

    abstract:INTRODUCTION:Biological markers specifically reflecting pathological processes may add value in the assessment of inter-individual variations in the course of rheumatoid arthritis (RA). The current study was undertaken to investigate whether baseline serum levels of the chemokine CXCL13 might predict clinical and ultra...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3742

    authors: Bugatti S,Manzo A,Benaglio F,Klersy C,Vitolo B,Todoerti M,Sakellariou G,Montecucco C,Caporali R

    更新日期:2012-02-15 00:00:00

  • Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.

    abstract:INTRODUCTION:Objectives were to investigate whether interactions between human osteoarthritic chondrocytes and 4-hydroxynonenal (HNE)-modified type II collagen (Col II) affect cell phenotype and functions and to determine the protective role of carnosine (CAR) treatment in preventing these effects. METHODS:Human Col I...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3173

    authors: El-Bikai R,Welman M,Margaron Y,Côté JF,Macqueen L,Buschmann MD,Fahmi H,Shi Q,Maghni K,Fernandes JC,Benderdour M

    更新日期:2010-01-01 00:00:00

  • Gene expression identifies patients who develop inflammatory arthritis in a clinically suspect arthralgia cohort.

    abstract:BACKGROUND:Established rheumatoid arthritis (RA) patients display differentially expressed genes coding for cytokine/chemokine-mediated immunity compared to healthy controls. It is unclear, however, if in the pre-arthritis phase of clinically suspect arthralgia (CSA) expression of immune genes differ between patients w...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02361-2

    authors: Niemantsverdriet E,van den Akker EB,Boeters DM,van den Eeden SJF,Geluk A,van der Helm-van Mil AHM

    更新日期:2020-11-09 00:00:00

  • The new era of autoimmune disease research.

    abstract::Recent genome-wide association studies have advanced our understanding of genetic factors that underlie systemic lupus erythematosus (SLE), a multifactorial autoimmune disease characterized by various clinical manifestations. SLE also has an environmental component, which can trigger or exacerbate the disease. Despite...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3335

    authors: Koike T

    更新日期:2011-05-31 00:00:00

  • Central pain contributions in osteoarthritis: next steps for improving recognition and treatment?

    abstract::There is increasing recognition that central pain sensitivity plays an important role in pain severity among patients with osteoarthritis. Murphy and colleagues identified clusters of patients with osteoarthritis according to pain severity and accompanying symptoms, and one of these groups appeared to have a greater d...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3499

    authors: Allen K

    更新日期:2011-01-01 00:00:00

  • The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

    abstract:INTRODUCTION:Despite recent advances in anti-inflammatory therapy, rheumatoid arthritis (RA) patients continue to rate pain as a priority. The etiology of RA pain is likely multifactorial, including both inflammatory and non-inflammatory components. In this study, we examine the association between disease activity, sl...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2842

    authors: Lee YC,Chibnik LB,Lu B,Wasan AD,Edwards RR,Fossel AH,Helfgott SM,Solomon DH,Clauw DJ,Karlson EW

    更新日期:2009-01-01 00:00:00

  • Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

    abstract::Advanced imaging techniques may enable early diagnosis and monitoring of therapy in various rheumatic diseases. To prevent irreversible tissue damage, inflammatory rheumatic disease must be diagnosed and treated in pre-clinical stages, requiring highly sensitive detection techniques. Positron emission tomography (PET)...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s13075-014-0423-2

    authors: Yamashita H,Kubota K,Mimori A

    更新日期:2014-01-01 00:00:00